Home

Transforming Healthcare with Evidence

hayesinfo@hayesinc.com | 215-855-0615




I consider Hayes to be the gold standard when it comes to the research and analysis of new medical technologies.

Anonymous
Current Client

News Service

American College of Cardiology Foundation Announces Patient-Centered Care Statement

Wednesday, May 16th, 2012

The concept of patient-centered care (PCC) is an increasingly hot topic in the ongoing discourse surrounding quality improvement. In an effort to shed light on the current state of PCC as it pertains to cardiovascular medicine, the American College of Cardiology Foundation (ACCF) released a special PCC-focused health policy statement on May 14.

(more…)

Hospital Strategies Linked to Fewer Deaths Following AMI

Tuesday, May 15th, 2012

A new study published in the Annals of Internal Medicine has identified five specific hospital performance strategies that result in lower 30-day risk-standardized mortality rates (RSMRs) for patients with acute myocardial infarction (AMI).

(more…)

FDA Snapshot

Monday, May 14th, 2012

First Oral Janus Kinase Inhibitor for Rheumatoid Arthritis Clears Regulatory Hurdle1

(more…)

FDA Warns Against CCSVI for Treating MS

Friday, May 11th, 2012

The Food and Drug Administration (FDA) is alerting healthcare professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency (CCSVI).

(more…)

Rethinking the Treatment of Urinary Tract Infections

Thursday, May 10th, 2012


In a surveillance study of more than 12 million bacteria, investigators at George Washington University found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections (UTI) in the United States, increased over fivefold from 2000 to 2010. In addition, nearly one in four isolates in 2010 were resistant to trimethoprim-sulfamethoxazole (TMP-SMX) (Bactrim®; Septra®), the second most commonly prescribed drug for this infection. Conversely, resistance to nitrofurantoin (Macrodantin®) and ceftriaxone (Rocephin™) showed minimal change.

(more…)

Urodynamic Testing Offers Little Benefit for Women with Uncomplicated SUI

Wednesday, May 9th, 2012

A set of invasive and costly tests commonly done in women before surgery for stress urinary incontinence (SUI) may not be necessary, according to a study funded by the National Institutes of Health and published in the New England Journal of Medicine.

(more…)

Treating Men with Prostate Cancer

Tuesday, May 8th, 2012


A research letter published in the Archives of Internal Medicine suggests that compared with younger men with a longer lifespan, older men with low-risk prostate cancer received increasingly aggressive curative treatment over a 10-year period. Curative treatment was defined as radiation therapy or prostatectomy within 9 months of being diagnosed with prostate cancer. Possible explanations for the treatment discrepancy include financial incentives, emergence of new therapies with perceived lower adverse effect profiles, and changes in patient preferences.

(more…)

Strong Link Between Healthcare-Associated Infections and Hospital Readmission

Monday, May 7th, 2012

New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.

(more…)

ACR Issues First Guidelines for Managing Lupus-Associated Nephritis

Friday, May 4th, 2012


The first guidelines for the screening and management of nephritis in patients with systemic lupus erythematosus (SLE) have been issued by the American College of Rheumatology.

(more…)

FDA Approves New Percutaneous Device for Abdominal Surgery

Thursday, May 3rd, 2012

The Food and Drug Administration (FDA) has allowed marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery.

(more…)

Stay Connected!

To receive email newsletters, updates, and special offers from Hayes, enter your email and press Submit.
Email

Social Media

More